Legal & General Group PLC Biotechnology

Legal & General Group PLC

$357 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BMEA Biomea Fusion, Inc.	$55.1M	$7,000 0.0% of portfolio	3,392	Q4 2023 Added 486.73%
KOD Kodiak Sciences Inc.	$270M	$7,000 0.0% of portfolio	2,747	Q3 2023 Reduced 17.16%
LCTX Lineage Cell Therapeutics, Inc.	$168M	$7,000 0.0% of portfolio	15,644	Q2 2023 New
MGNX Macrogenics Inc	$94.6M	$7,000 0.0% of portfolio	6,140	Q4 2023 Added 54.02%
TNGX Tango Therapeutics, Inc.	$604M	$7,000 0.0% of portfolio	5,345	Q4 2023 Added 581.14%
ZNTL Zentalis Pharmaceuticals, Inc.	$82.1M	$7,000 0.0% of portfolio	4,940	Q4 2023 Added 1,025.04%
CRBU Caribou Biosciences, Inc.	$111M	$6,000 0.0% of portfolio	6,941	Q4 2023 Added 12.06%
FATE Fate Therapeutics Inc	$112M	$6,000 0.0% of portfolio	8,644	Q4 2023 Added 103.96%
GLSI Greenwich Life Sciences, Inc.	$158M	$6,000 0.0% of portfolio	662	Q2 2024 New
THRD Third Harmonic Bio, Inc.	$219M	$6,000 0.0% of portfolio	1,954	Q4 2023 Reduced 17.76%
VTYX Ventyx Biosciences, Inc.	$185M	$6,000 0.0% of portfolio	5,981	Q4 2023 Added 610.65%
VERU Veru Inc.	$48.9M	$6,000 0.0% of portfolio	13,684	Q2 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$40.8M	$5,000 0.0% of portfolio	3,713	Q4 2023 Reduced 18.72%
BDTX Black Diamond Therapeutics, Inc.	$118M	$5,000 0.0% of portfolio	3,825	Q2 2024 New
CABA Cabaletta Bio, Inc.	$49.3M	$5,000 0.0% of portfolio	3,961	Q4 2023 Added 546.58%
LXRX Lexicon Pharmaceuticals, Inc.	$255M	$5,000 0.0% of portfolio	11,466	Q4 2023 Reduced 2.69%
TCRX T Scan Therapeutics, Inc.	$35.6M	$5,000 0.0% of portfolio	3,937	Q2 2024 New
XBIT X Biotech Inc.	$91.3M	$5,000 0.0% of portfolio	1,598	Q2 2024 New
HLVX Hille Vax, Inc.	$68.9M	$4,000 0.0% of portfolio	2,884	Q4 2023 Added 258.08%
INZY Inozyme Pharma, Inc.	$161M	$4,000 0.0% of portfolio	4,813	Q4 2023 Reduced 16.21%
PYXS Pyxis Oncology, Inc.	$41.8M	$4,000 0.0% of portfolio	4,219	Q2 2024 New
STRO Sutro Biopharma, Inc.	$40.2M	$4,000 0.0% of portfolio	7,073	Q4 2023 Reduced 29.87%
XFOR X4 Pharmaceuticals, Inc	$99.5M	$4,000 0.0% of portfolio	18,609	Q4 2023 Reduced 39.14%
ABOS Acumen Pharmaceuticals, Inc.	$59.9M	$3,000 0.0% of portfolio	3,635	Q2 2024 New
MRSN Mersana Therapeutics, Inc.	$35M	$3,000 0.0% of portfolio	11,097	Q4 2023 Added 166.08%
NAUT Nautilus Biotechnology, Inc.	$91M	$3,000 0.0% of portfolio	4,148	Q4 2023 Reduced 14.21%
STTK Shattuck Labs, Inc.	$31.4M	$3,000 0.0% of portfolio	4,027	Q2 2024 New
TNYA Tenaya Therapeutics, Inc.	$36M	$3,000 0.0% of portfolio	5,802	Q4 2023 Reduced 26.73%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$2,000 0.0% of portfolio	1,128	Q4 2023 Added 47.7%
ALXO Alx Oncology Holdings Inc	$20M	$2,000 0.0% of portfolio	3,860	Q4 2023 Reduced 40.7%
IGMS Igm Biosciences, Inc.	$36.8M	$2,000 0.0% of portfolio	1,746	Q4 2023 Reduced 9.05%
OVID Ovid Therapeutics Inc.	$33.8M	$2,000 0.0% of portfolio	6,579	Q4 2023 Reduced 20.95%
PEPG Pep Gen Inc.	$28.8M	$2,000 0.0% of portfolio	1,678	Q4 2023 Reduced 49.17%
RAPT Rapt Therapeutics, Inc.	$303M	$2,000 0.0% of portfolio	2,379	Q4 2023 Added 781.34%
HOWL Werewolf Therapeutics, Inc.	$41.3M	$2,000 0.0% of portfolio	2,642	Q2 2024 New
IPSC Century Therapeutics, Inc.	$34.2M	$1,000 0.0% of portfolio	3,976	Q4 2023 Reduced 46.86%
ELEV Elevation Oncology, Inc.	$8.62M	$1,000 0.0% of portfolio	5,287	Q2 2024 New
GBIO Generation Bio Co.	$30.7M	$1,000 0.0% of portfolio	3,919	Q3 2023 Reduced 17.94%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	35,341	Q4 2023 Reduced 20.33%
GALT Galectin Therapeutics Inc	$172M	$0 0.0% of portfolio	38	Q2 2024 Added 6,431.58%
PRLD Prelude Therapeutics Inc	$29.8M	$0 0.0% of portfolio	962	Q2 2023 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.